No Data
No Data
Why Is OPKO Health (OPK) Up 12.8% Since Last Earnings Report?
Global Tetraspecific Antibodies Clinical Trials & Market Opportunity Report 2024 Featuring Innate Pharma, ModeX Therapeutics, Molecular Partners, OPKO Health, Sichuan Baili Pharmaceutical, SystImmune - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Tetraspecific Antibodies Clinical Trials & Market Opportunity Insight 2024" report has been added to ResearchAndMarkets.com's offering.Global Tetraspecific Antibod
Bullish OPKO Health Insiders Loaded Up On US$12.9m Of Stock
OPKO Health to Participate in the Jefferies Global Healthcare Conference
MIAMI, May 31, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Global Healthcare Conference, being held June 4-6, 2024
Ondas Holdings And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed lower by over 600 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders i
Opko Health(OPK.US) 10% Shareholder Buys US$126.94K in Common Stock
$Opko Health(OPK.US)$ 10% Shareholder FROST PHILLIP MD purchased 100K shares of common stock on May 23, 2024 at an average price of $1.2694 for a total value of $126.94K. This transaction involves ot
No Data
Trytosaveabit : Yes let’s! Hehehe GL![undefined undefined](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)